Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement GMP Compliance Means Staying On Top Of Reasons For Consumer Doubt

This article was originally published in The Tan Sheet

Executive Summary

Consumers have a new reason to doubt supplement safety “every single day,” says Lisa Thomas, general manager of NSF’s Certified for Sport program. More NSF clients are correcting GMP problems after an initial audit, “a really good thing because nobody likes to tell you to do something and then have to tell you again, especially the FDA,” she says.

You may also be interested in...



NSF ‘Certified For Sport’ Apps Cuts Through Unsafe Supplement Clutter

NSF International introduces Certified for Sport app to identify its 700 certified supplement products by scanning a product barcode and also connect to brands' e-commerce site. Since a hard launch in late January, NSF says downloads are “in the thousands.”

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107621

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel